Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
Active, not recruiting · NCT05143840 · Registry updated 2026-07-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 2 | 2026-07-22 | NCT05143840 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| H. Jean Khoury Cure CML Consortium | 3 |
| University of Alabama at Birmingham | 467 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Froedtert Hospital & the Medical College of Wisconsin | Milwaukee | United States | 31 |
| Georgia Cancer Center at Augusta University | Augusta | United States | 23 |
| Huntsman Cancer Institute | Salt Lake City | United States | 107 |
| Karmanos Cancer Institute | Detroit | United States | 153 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Roswell Park Comprehensive Cancer Center | Buffalo | United States | 63 |
| University of Alabama at Birmingham | Birmingham | United States | 247 |
| Winship Cancer Institute Emory University | Atlanta | United States | 11 |